Potential advantages of direct-acting thrombin inhibitors

Coron Artery Dis. 1996 Jul;7(7):497-507. doi: 10.1097/00019501-199607000-00003.
No abstract available

Publication types

  • Review

MeSH terms

  • Angina, Unstable / drug therapy*
  • Angioplasty, Balloon, Coronary
  • Animals
  • Anticoagulants / pharmacology*
  • Antithrombin III / pharmacology
  • Clinical Trials as Topic
  • Fibrinolytic Agents / pharmacology*
  • Heparin / pharmacology*
  • Hirudin Therapy
  • Hirudins / pharmacology*
  • Humans
  • Myocardial Infarction / drug therapy
  • Randomized Controlled Trials as Topic
  • Thrombin / antagonists & inhibitors*
  • Thrombin / physiology
  • Thrombolytic Therapy*

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Hirudins
  • Antithrombin III
  • Heparin
  • Thrombin